Xcelience boosts solid oral dosage form capabilities

Contract research manufacturer Xcelience has expanded its solid oral dosage form capabilities by adding a Vector TFC-220 roller compactor. The new gear aids drug developers in the transition to GMP production of clinical supplies. Xcelience last March announced its alliance with three other contractors to provide a project management service that streamlines hand-offs between drugmakers and contractors throughout the various stages of drug development. Xcelience release

Suggested Articles

Recipharm has been building its capabilities in sterile injectable and inhalation drugs. Now it is buying a CDMO that manufactures devices for both.

The FDA has slapped the parent of Dollar Tree stores with a warning letter saying some CMOs that made its OTC products were among the world's worst.

GSK expects Shingrix supplies to rise slightly in 2020, but the real "step change" will come in 2024 with a brand-new manufacturing facility.